Concepedia

Jacques Y. Roberge

JY

Statistics

Publications

28

Citations

896

H-Index

18

Active since

1991

Affiliations

Rutgers, The State University of New Jersey(Current)

Bristol-Myers Squibb (United States)

Johnson University

Kettering University

Theracos (United States)

Jacques Y. Roberge is an author at Rutgers, The State University of New Jersey specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1991–2024

28

Publications

28

EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats

Wenbin Zhang, Ajith Welihinda, Jordan Mechanic et al. · Pharmacological Research · 2011 · 76 citations

, , +13

A Strategy for a Convergent Synthesis of N-Linked Glycopeptides on a Solid Support

Jacques Y. Roberge, Xenia Beebe, Samuel J. Danishefsky · Science · 1995 · 76 citations

, , +17

Convergent Synthesis of <i>N</i>-Linked Glycopeptides on a Solid Support

Jacques Y. Roberge, Xenia Beebe, Samuel J. Danishefsky · Journal of the American Chemical Society · 1998 · 70 citations

, , +17

Discovery of 2-(Phenoxypyridine)-3-phenylureas as Small Molecule P2Y<sub>1</sub> Antagonists

Hannguang J. Chao, Huji Turdi, Timothy F. Herpin et al. · Journal of Medicinal Chemistry · 2013 · 64 citations · Full text

, , +17

Design, Synthesis, and Biological Evaluation of Deuterated <i>C</i>-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes

Ge Xu, Binhua Lv, Jacques Y. Roberge et al. · Journal of Medicinal Chemistry · 2014 · 63 citations · Full text

, , +17

1–5 of 28